Abdullahi Balarabe Nazifi

Abdullahi Balarabe Nazifi

Auto-generated profile, based on publicly available information

Abdullahi Balarabe Nazifi

Department of Pharmacology and Therapeutics , Bayero University , Kano , Nigeria

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2015 in Journal of Pharmacy & Bioresources
Verified
Journal Article
Closed access
PDF file
ANAbdullahi Balarabe Nazifi
Abdullahi Balarabe Nazifi
OSOdoma Saidi
Odoma Saidi
HIHassan Fatima Ismail
Hassan Fatima Ismail
Evaluation of anticonvulsant effects of methanolic extract of Olax subscorpioidea Oliv. leaves in chicks and mice

19 October 2023 in Journal of Pharmacy & Bioresources
Verified
Journal Article
Open access
PDF file
ANAbdullahi Balarabe Nazifi
Abdullahi Balarabe Nazifi
AAAbdulhakim Abubakar
Abdulhakim Abubakar
MMMohammed Garba Magaji
Mohammed Garba Magaji
MAMusa Aliyu
Musa Aliyu
AYAbdullahi Hamza Yaro
Abdullahi Hamza Yaro
NDNuhu Mohammed Danjuma
Nuhu Mohammed Danjuma
Eragrostis tremula is utilized in Nigeria and other African countries as a memory enhancer, lactation stimulant, antiemetic, aphrodisiac and remedy for snake bites. Scientific reports revealed that this plant has anti-oxidant, anticholinesterase, cytotoxic and memory enhancing properties; despite these potentials, there is paucity of safety data to support its continued usage. This study investigated the toxicity profile of hydroethanolic extract of E. tremula (HEET) in Wistar rats. Acute and sub-acute (28 days at doses of 250, 500 and 1000 mg/kg per oral) toxicity tests were conducted using OECD 425 and 407 guidelines respectively. Limit test at 5,000 mg/kg was conducted to ascertain the midpoint lethal dose (LD50). The LD50 of HEET was above 5000 mg/kg per oral and no significant alterations in haematological parameters and tissue morphology were observed. In the sub-acute study, no death was recorded. There were no changes in food intake, organ/body weight, lipid profile, liver and renal function indices. However, histology of the kidneys showed slight tubular adhesion and glomerular necrosis. HEET was practically safe after acute administration with no practical deleterious effect at 250 mg/kg after prolonged administration in rats. However, 28 days administration of high doses caused slight kidney injury.

18 April 2022 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
ANAbdullahi Balarabe Nazifi
Abdullahi Balarabe Nazifi
AAAbdulhakim Abubakar
Abdulhakim Abubakar
MMMohammed Garba Magaji
Mohammed Garba Magaji
MAMusa Aliyu
Musa Aliyu
NDNuhu Mohammed Danjuma
Nuhu Mohammed Danjuma
Background: Eragrostis tremula Hochst. ex Steud. (Poaceae) is used in ethno-medicine as a memory enhancer. Studies have shown that the whole plant possesses memory enhancing potentials and could be beneficial in the management of amnesia and cognitive deficit. Aim: This study was aimed at investigating the actions of E. tremula extract on diazepam-induced amnesia in mice. Acute toxicity profiling was done as stated by the Organization for Economic Co-operation and Development (OECD 425). Oral doses of 125, 250 and 500 mg/kg of E. tremula extract were used for the diazepam-induced amnesia studies. Cognitive function was evaluated using elevated plus maze (EPM) and novel object recognition tests (NORT). The brain tissues were evaluated for the concentrations of malondialdehyde (MDA), reduced glutathione (GSH) and superoxide dismutase (SOD) using enzyme-linked immunosorbent assay kits. Results: The oral median toxic dose of E. tremula extract was assessed to be > 5000 mg/kg in mice. The extract substantially (p < 0.05) reduced the transfer latency of mice during the retention phase of EPM test. In the NORT, E. tremula extract at all the doses appreciably (p < 0.05) reduced the exploration time on the familiar object. Also, it substantially (p < 0.05) improved the recognition index. E. tremula extract substantially (p < 0.05) reduced the MDA levels, and at doses of 250 and 500 mg/kg, it prevented the cortical and hippocampal tissues from lesions produced by diazepam. Conclusions: Eragrostis tremula extract is practically safe after acute administration and possesses anti-amnesic actions.

13 August 2021 in Drug Metabolism and Personalized Therapy
Verified
Journal Article
Closed access
AAAbdulhakim Abubakar
Abdulhakim Abubakar
ANAbdullahi Balarabe Nazifi
Abdullahi Balarabe Nazifi
IMIdris Mohammed Maje
Idris Mohammed Maje
YTYusuf Tanko
Yusuf Tanko
JAJoseph Akpojo Anuka
Joseph Akpojo Anuka
EAEzzeldin Mukthar Abdurahman
Ezzeldin Mukthar Abdurahman
Objectives: Chlorophytum alismifolium (C. alismifolium) tubers are used in the management of diabetes. This research evaluated the effect of ethylacetate extract of C. alismifolium (EACA) on microvascular complications and the possible association of oxidative stress and aldose reductase in type 2 diabetic rats. Methods: C. alismifolium tubers were subjected to sequential extraction until ethylacetate extract was obtained using a soxhlet apparatus. The LD50 was determined using the OECD 425 guideline. The animals were placed on high fat diet for 42 days and then induced with hyperglycaemia using 40 mg/kg of streptozotocin. Diabetic neuropathy was evaluated using thermal and mechanical methods. Serum was used for the assessment of oxidative stress markers and biochemical markers of retinopathy and nephropathy. Serum aldose reductase was investigated by utilizing the principle of enzyme-linked immunosorbent assay. Results: The median lethal dose of EACA was assessed to be above 5,000 mg/kg and it caused no mortality. Treatment with EACA significantly reduced the withdrawal times in both thermal and mechanical hyperalgesic methods (p<0.05). EACA also significantly reduced the levels of urea (p<0.001), albumin (p<0.05) and uric acid (p<0.001) in hyperglycaemic rats. EACA significantly decreased the amounts of low density lipoprotein and triglycerides (p<0.001). There was a remarkable elevation in the levels of high density lipoprotein (p<0.05). A significant (p<0.05) increase in the levels of magnesium was observed in the EACA-treated groups. EACA significantly increased catalase (p<0.05) and reduced malondialdehyde levels (p<0.05). The levels of aldose reductase was significantly (p<0.001) reduced by EACA compared to the hyperglycaemic control. Conclusions: The ethylacetate extract of C. alismifolium has beneficial effects in alleviating microvascular complications of diabetes through the inhibition of oxidative stress and aldose reductase in diabetic rats.

13 August 2021 in Drug Metabolism and Personalized Therapy
Verified
Journal Article
Closed access
AAAbdulhakim Abubakar
Abdulhakim Abubakar
ANAbdullahi Balarabe Nazifi
Abdullahi Balarabe Nazifi
IMIdris Mohammed Maje
Idris Mohammed Maje
YTYusuf Tanko
Yusuf Tanko
JAJoseph Akpojo Anuka
Joseph Akpojo Anuka
EAEzzeldin Mukthar Abdurahman
Ezzeldin Mukthar Abdurahman
Objectives: Chlorophytum alismifolium ( C. alismifolium ) tubers are used in the management of diabetes. This research evaluated the effect of ethylacetate extract of C. alismifolium (EACA) on microvascular complications and the possible association of oxidative stress and aldose reductase in type 2 diabetic rats. Methods: C. alismifolium tubers were subjected to sequential extraction until ethylacetate extract was obtained using a soxhlet apparatus. The LD 50 was determined using the OECD 425 guideline. The animals were placed on high fat diet for 42 days and then induced with hyperglycaemia using 40 mg/kg of streptozotocin. Diabetic neuropathy was evaluated using thermal and mechanical methods. Serum was used for the assessment of oxidative stress markers and biochemical markers of retinopathy and nephropathy. Serum aldose reductase was investigated by utilizing the principle of enzyme-linked immunosorbent assay. Results: The median lethal dose of EACA was assessed to be above 5,000 mg/kg and it caused no mortality. Treatment with EACA significantly reduced the withdrawal times in both thermal and mechanical hyperalgesic methods (p<0.05). EACA also significantly reduced the levels of urea (p<0.001), albumin (p<0.05) and uric acid (p<0.001) in hyperglycaemic rats. EACA significantly decreased the amounts of low density lipoprotein and triglycerides (p<0.001). There was a remarkable elevation in the levels of high density lipoprotein (p<0.05). A significant (p<0.05) increase in the levels of magnesium was observed in the EACA-treated groups. EACA significantly increased catalase (p<0.05) and reduced malondialdehyde levels (p<0.05). The levels of aldose reductase was significantly (p<0.001) reduced by EACA compared to the hyperglycaemic control. Conclusions: The ethylacetate extract of C. alismifolium has beneficial effects in alleviating microvascular complications of diabetes through the inhibition of oxidative stress and aldose reductase in diabetic rats.

6 January 2026 in Journal of Pharmacy & Bioresources
Verified
Journal Article
Open access
PDF file
ANAbdullahi Balarabe Nazifi
Abdullahi Balarabe Nazifi
FAFatima Abdulwahid Abubakar
Fatima Abdulwahid Abubakar
AAAbdulhakim Abubakar
Abdulhakim Abubakar
FHFatima Ismail Hassan
Fatima Ismail Hassan
MAMusa Aliyu
Musa Aliyu
Terminalia mollis (Family: Combretaceae) is used in ethno-medicine as an inflammatory and analgesic agent. This study investigated the analgesic activity of methanol extract of T. mollis leaves (METM) in rodents and its potential mechanism of action. Phytochemical investigation of METM was done, followed by acute toxicity study in mice and rats. METM was subjected to anti-nociceptive studies (thermal nociception, acetic acid-induced writhing and formalin tests) at doses of 150-600 mg/kg. Phyto-constituents present include anthraquinones, cardiac glycosides, saponins, steroids, flavonoids, tannins and triterpenes. The oral median lethal dose was >2000 mg/kg in mice and rats. METM notably (p<0.05) reduced the writhing response at all the tested doses and offered 76.2% protection against pain at 300 mg/kg. A significant (p<0.05) decrease in paw-licking was observed in the formalin test. There was a significant (p<0.05) increase in reaction time as compared to control and over time in the thermal nociception test. In the mechanistic studies, pre-dosing of mice with glibenclamide and naloxone appreciably reversed the actions of METM. However, pre-treatment with atropine, prazosin and yohimbine did not affect the actions of METM. The findings suggest the involvement of KATP channel and opioidergic pathway in the antinociceptive activity of METM.